Time of administration of filgrastim affects NEO-201 PK
neutropenia
NEUTROPENIA
Ten of 17 patients (4 in DL 2 and 6 in DL 1.5) received filgrastim to shorten the duration of the neutropenia.In the DL 2 cohort, time of administration of filgrastim to mitigate neutropenia had an impact on NEO-201 concentration in the serum of some patients (Supplementary Fig. 